Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis

Posted by Leanne Kodsman on

Pooled Normal Human Serum from Innovative Research was recently used in the following study:

Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis

Yan Li, Fiona Clow, John D. Fraser, Feng Lin
Journal of Molecular Medicine, September 2018

" ... Recombinant SSL7 and SSL7-C5a SSL7 mutant lacking C5 binding activity were overexpressed in Escherichia coli and purified following the protocol described in previous reports [16, 20]. Pooled normal human serum (NHS) as the source of complement was purchased from Innovative Research (Novi, MI)."

Related products available from Innovative Research also include:

  • Tags: Human Serum, Pooled Human Serum Off The Clot

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!



    ← Older Post Newer Post →